Saudi Arabia
August 2024
Under its overarching ‘Vision 2030’ economic diversification plan, Saudi is aiming to play a much greater regional and global role in everything from artificial intelligence to sport and, significantly, healthcare. Ambitious and wide-ranging transformation plans are in place to raise health span and deepen care coverage, while local and female participation in the workforce is gathering speed, and the country’s youth are more empowered than ever before.
Saudis are demanding ever more sophisticated and comprehensive public and private health services, and the system is adapting accordingly, with private sector input into both the hardware and software of health a critical component.
Elsewhere, the country’s dense network of local manufacturers has been making strenuous efforts to scale the value chain and develop its own proprietary formulations. This network is also working to produce vital medicines and vaccines in-country, contributing to the nation’s medicinal sovereignty along the way.
Finally, in-line with broader goals to make the country not just a consumer, but a source, of innovation, researchers are doubling down on earlier-stage clinical trials to turn Saudi into a regional biotech innovation hub by 2030 and a global one by 2050.
Through conversations with over 40 leading public and private stakeholders, this report sheds light on the astounding progress that Saudi healthcare has already made and the major plans to bolster it even further. It addresses some of the key pain points still to cover and the massive market opportunities for canny and committed investors to consider.
Under its overarching ‘Vision 2030’ economic diversification plan, Saudi is aiming to play a much greater regional and global role in everything from artificial intelligence to sport and, significantly, healthcare. Ambitious and wide-ranging transformation plans are in place to raise health span and deepen care coverage, while local and female participation in the workforce is gathering speed, and the country’s youth are more empowered than ever before.
Saudis are demanding ever more sophisticated and comprehensive public and private health services, and the system is adapting accordingly, with private sector input into both the hardware and software of health a critical component.
Elsewhere, the country’s dense network of local manufacturers has been making strenuous efforts to scale the value chain and develop its own proprietary formulations. This network is also working to produce vital medicines and vaccines in-country, contributing to the nation’s medicinal sovereignty along the way.
Finally, in-line with broader goals to make the country not just a consumer, but a source, of innovation, researchers are doubling down on earlier-stage clinical trials to turn Saudi into a regional biotech innovation hub by 2030 and a global one by 2050.
Through conversations with over 40 leading public and private stakeholders, this report sheds light on the astounding progress that Saudi healthcare has already made and the major plans to bolster it even further. It addresses some of the key pain points still to cover and the massive market opportunities for canny and committed investors to consider.
See more
